Xu Jun, Tang Qing, Zhang Runhui, Chen Haoyi, Khoo Bee Luan, Zhang Xinguo, Chen Yue, Yan Hong, Li Jincheng, Shao Huaze, Liu Lihong
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
The Second Clinical Medical School, Southern Medical University, Guangzhou, 510515, China.
J Pharm Anal. 2022 Oct;12(5):808-813. doi: 10.1016/j.jpha.2022.05.009. Epub 2022 Jun 1.
The identification of tumor-related microRNAs (miRNAs) exhibits excellent promise for the early diagnosis of cancer and other bioanalytical applications. Therefore, we developed a sensitive and efficient biosensor using polyadenine (polyA)-mediated fluorescent spherical nucleic acid (FSNA) for miRNA analysis based on strand displacement reactions on gold nanoparticle (AuNP) surfaces and electrokinetic signal amplification (ESA) on a microfluidic chip. In this FSNA, polyA-DNA biosensor was anchored on AuNP surfaces via intrinsic affinity between adenine and Au. The upright conformational polyA-DNA recognition block hybridized with 6-carboxyfluorescein-labeled reporter-DNA, resulting in fluorescence quenching of FSNA probes induced by AuNP-based resonance energy transfer. Reporter DNA was replaced in the presence of target miRNA, leading to the recovery of reporter-DNA fluorescence. Subsequently, reporter-DNAs were accumulated and detected in the front of with Nafion membrane in the microchannel by ESA. Our method showed high selectivity and sensitivity with a limit of detection of 1.3 pM. This method could also be used to detect miRNA-21 in human serum and urine samples, with recoveries of 104.0%-113.3% and 104.9%-108.0%, respectively. Furthermore, we constructed a chip with three parallel channels for the simultaneous detection of multiple tumor-related miRNAs (miRNA-21, miRNA-141, and miRNA-375), which increased the detection efficiency. Our universal method can be applied to other DNA/RNA analyses by altering recognition sequences.
肿瘤相关微小RNA(miRNA)的识别在癌症早期诊断及其他生物分析应用方面展现出了巨大潜力。因此,我们基于金纳米颗粒(AuNP)表面的链置换反应和微流控芯片上的电动信号放大(ESA),开发了一种利用聚腺嘌呤(polyA)介导的荧光球形核酸(FSNA)进行miRNA分析的灵敏高效生物传感器。在这种FSNA中,polyA - DNA生物传感器通过腺嘌呤与金之间的固有亲和力锚定在AuNP表面。直立构象的polyA - DNA识别模块与6 - 羧基荧光素标记的报告DNA杂交,导致基于AuNP的共振能量转移引起FSNA探针荧光猝灭。在靶miRNA存在的情况下,报告DNA被置换,从而使报告DNA荧光恢复。随后,通过ESA在微通道中用Nafion膜在前面累积并检测报告DNA。我们的方法具有高选择性和灵敏度,检测限为1.3 pM。该方法还可用于检测人血清和尿液样本中的miRNA - 21,回收率分别为104.0% - 113.3%和104.9% - 108.0%。此外,我们构建了一个具有三个平行通道的芯片,用于同时检测多种肿瘤相关miRNA(miRNA - 21、miRNA - 141和miRNA - 375),提高了检测效率。通过改变识别序列,我们的通用方法可应用于其他DNA/RNA分析。